Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Study finds GLP-1 drugs may reduce risk of more than a dozen cancers, offering hope in Louisiana where obesity-related cancer ...

Weight loss pills and injections are two forms of medication used to help people lose weight. There are a number of medications approved for weight loss and they can work in a variety of ways, such as ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used that there ...

On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage List since 2022 because demand for the drug ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and diabetes ...

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...

Researchers discovered semaglutide—the active ingredient in Ozempic and Wegovy—may reduce the risk of death and lower the chance of developing cardiovascular conditions like stroke and heart attack in ...

ONE GRAND PRIX THIS WEEKEND. FIVE ON YOUR HEALTH TONIGHT. SEVERE SIDE EFFECTS FROM SEMAGLUTIDE, A NATIONAL STUDY FINDS THEY SENT NEARLY 25,000 PEOPLE TO THE ER FOR TREATMENT. JOINING US NOW IS DOCTOR ...